HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Efficacy data, cost-effectiveness will guide decision to expand HPV vaccination to older adults
• Which is the better use of resources: increasing HPV vaccine uptake or developing new vaccines that protect against all oncogenic HPV strains?
• Cost-effectiveness and common sense John Sweetenham, MD, FRCP, FACP
• Translating an explosion of knowledge in molecular oncology Wafik S. El-Deiry, MD, PhD, FACP
• Many breast cancer survivors do not receive recommended mammograms
• Whole genome-based antigen testing may improve transfusion outcomes
• Trial represents ‘bold move’ for treatment of newly diagnosed myeloma
• Rucaparib induces response in BRCA-mutated pancreatic cancer
• Androgen deprivation therapy increases risk for rheumatoid arthritis
• ACCC National Oncology Conference to bring ‘new insights into action’
• Tomosynthesis plus mammography increases breast cancer detection by 90%
• Molecular minimal residual disease predicts poor outcomes for acute myeloid leukemia
• Novel imaging offers insights on engraftment process after HSCT
• Childhood bone marrow transplant recipients at risk for late mortality
• Interventions crucial to offset negative impact of psychological symptoms on childhood cancer survivors
• Shorter adjuvant chemotherapy duration may be sufficient for stage III colon cancer
• Tumor sequencing superior to other methods of detecting Lynch syndrome in colorectal cancer
• Combination immunotherapy, chemotherapy feasible in metastatic bladder cancer
• Marijuana use improves quality of life for patients with head, neck cancer
• Early dinner associated with reduced risk for prostate, breast cancer
• Adverse skin reactions can occur months after anti-PD-1 treatment
• Brigatinib confers intracranial responses in ALK-positive non-small cell lung cancer
• Breast cancer diagnosed after negative mammogram has worse prognosis
• IV immunoglobulin does not prevent chronic immune thrombocytopenia among children
• FDA approves Azedra for rare adrenal gland tumors
• FDA grants FLT3 inhibitor breakthrough therapy designation for acute myeloid leukemia
• FDA clears Sentimag System for lymph node detection in breast cancer
• FDA expands indication of SAVI SCOUT reflector to include localization of soft tissue
• FDA grants Braftovi-Mektovi plus Erbitux breakthrough therapy designation for colorectal cancer
• FDA approves Mulpleta for thrombocytopenia in adults with chronic liver disease
• FDA approves Poteligeo for mycosis fungoides, Sézary syndrome
• Collaboration needed to complete clinical trials of proton therapy
• Cancer centers join forces to eliminate HPV-related cancers
• Immunotherapy researchers to share Albany Prize
• Penn dermatologist receives award for skin cancer research
• The University of Texas MD Anderson Cancer Center ranked best cancer hospital in country
• Radiation oncology organization elects president